ArticleFrontiers in nutrition2026
The prognostic nutritional index (PNI) and sepsis-induced cardiomyopathy (SCM) risk in the ICU: a retrospective study with L-shaped analysis.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis-induced cardiomyopathy (SCM) is a common complication in patients with sepsis. Although the prognostic nutritional index (PNI) is less comprehensive than other assessment methods, it remains a readily accessible indicator of nutritional and immune status. This study aimed to investigate the relationship between SCM and the PNI. Methods: This retrospective study included 200 septic patients admitted to the intensive care unit (ICU) at Linyi City People's Hospital from 2023 to 2025. The primary endpoint was the occurrence of SCM during the ICU stay. Patients lacking essential variables (e.g., N-terminal pro-B-type natriuretic peptide [NT-proBNP] and ejection fraction [EF]) were excluded from the study. Missing data for other variables were imputed using multiple imputation methods. Restricted cubic spline (RCS) analysis and multivariate logistic regression analyses were performed to evaluate the relationship between SCM and the PNI. Subgroup analyses validated the robustness of the findings. Results: SCM occurred in 63% of the study population, with incidence rates of 83.33, 61.19, and 44.78% in the T1 (PNI < 31.3), T2 (31.3 ≤ PNI < 38.65), and T3 (PNI ≥ 38.65) groups, respectively. A multivariate logistic regression analysis revealed a significant inverse association between the PNI and SCM (OR = 0.909, 95% CI: 0.862-0.955). Compared with the T1 group, the T3 and T2 groups had significantly lower SCM risks (OR = 0.162, 95% CI: 0.069-0.356; OR = 0.315, 95% CI: 0.135-0.700, respectively). The RCS analysis demonstrated an L-shaped relationship between the PNI and SCM risk, indicating a 10% reduction in risk per unit increase in PNI when the PNI was below 35. Subgroup analyses confirmed these results. Conclusion: The PNI showed a negative, L-shaped association with the risk of SCM. These findings suggest that PNI can serve as an early risk stratification tool for SCM in septic patients, facilitating timely clinical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.